# Vijeta Bhambhani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/vijeta-bhambhani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,081 |
| Field | Heart Failure Treatment and Management |
| h-index | 16 |
| i10-index | 17 |
| Last Known Institution | Verastem (United States) |
| OpenAlex ID | https://openalex.org/A5004882437 |
| Works | 35 |

## Researcher papers

- [The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF](https://scholariq.org/papers/the-association-of-obesity-and-cardiometabolic-traits-with-incident-hfpef-and/)
- [Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation](https://scholariq.org/papers/surgery-does-not-improve-survival-in-patients-with-isolated-severe-tricuspid/)
- [Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction](https://scholariq.org/papers/association-of-cardiovascular-biomarkers-with-incident-heart-failure-with/)
- [Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans](https://scholariq.org/papers/adipsin-preserves-beta-cells-in-diabetic-mice-and-associates-with-protection/)
- [Sex Differences in Circulating Biomarkers of Cardiovascular Disease](https://scholariq.org/papers/sex-differences-in-circulating-biomarkers-of-cardiovascular-disease/)
- [Predictors and Outcomes of Heart Failure with Mid-Range Ejection Fraction](https://scholariq.org/papers/predictors-and-outcomes-of-heart-failure-with-mid-range-ejection-fraction/)
- [Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial](https://scholariq.org/papers/safety-and-efficacy-of-hydrothermal-duodenal-mucosal-resurfacing-in-patients/)
- [Obesity Is Associated With Pulmonary Hypertension and Modifies Outcomes](https://scholariq.org/papers/obesity-is-associated-with-pulmonary-hypertension-and-modifies-outcomes/)
- [Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes](https://scholariq.org/papers/longitudinal-change-in-galectin-3-and-incident-cardiovascular-outcomes/)
- [Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study)](https://scholariq.org/papers/durable-metabolic-improvements-2-years-after-duodenal-mucosal-resurfacing-dmr-in/)
- [Implementation of Instrument-Based Vision Screening for Preschool-Age Children in Primary Care](https://scholariq.org/papers/implementation-of-instrument-based-vision-screening-for-preschool-age-children/)
- [Effect of Instrument-Based Vision Screening for 3- to 5-Year-Old Children on Referrals to Eye Care Specialists](https://scholariq.org/papers/effect-of-instrument-based-vision-screening-for-3-to-5-year-old-children-on/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac Health and Mental Health](https://scholariq.org/topics/cardiac-health-and-mental-health/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

## Researcher university

- [Verastem (United States)](https://scholariq.org/institutions/verastem-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.